News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
430,600 Results
Type
Article (24946)
Company Profile (233)
Press Release (405421)
Multimedia
Podcasts (44)
Webinars (8)
Section
Business (123626)
Career Advice (434)
Deals (20613)
Drug Delivery (77)
Drug Development (49247)
Employer Resources (76)
FDA (11754)
Job Trends (10050)
News (208448)
Policy (20181)
Tag
Academia (2129)
Academic (1)
Accelerated approval (4)
Adcomms (12)
Allergies (68)
Alliances (34725)
ALS (75)
Alzheimer's disease (957)
Antibody-drug conjugate (ADC) (91)
Approvals (11824)
Artificial intelligence (237)
Autoimmune disease (13)
Automation (13)
Bankruptcy (136)
Best Places to Work (8978)
BIOSECURE Act (14)
Biosimilars (76)
Biotechnology (167)
Bladder cancer (62)
Brain cancer (23)
Breast cancer (209)
Cancer (1725)
Cardiovascular disease (150)
Career advice (387)
Career pathing (13)
CAR-T (123)
Cell therapy (341)
Cervical cancer (15)
Clinical research (41060)
Collaboration (772)
Compensation (291)
Complete response letters (9)
COVID-19 (1687)
CRISPR (42)
C-suite (220)
Cystic fibrosis (69)
Data (1819)
Decentralized trials (1)
Denatured (25)
Depression (30)
Diabetes (213)
Diagnostics (4382)
Digital health (15)
Diversity (6)
Diversity, equity & inclusion (26)
Drug discovery (103)
Drug pricing (81)
Drug shortages (18)
Duchenne muscular dystrophy (71)
Earnings (43927)
Editorial (17)
Employer branding (6)
Employer resources (69)
Events (65183)
Executive appointments (660)
FDA (12817)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (640)
Gene editing (97)
Generative AI (21)
Gene therapy (247)
GLP-1 (503)
Government (3332)
Grass and pollen (4)
Guidances (46)
Healthcare (13843)
Huntington's disease (13)
IgA nephropathy (21)
Immunology and inflammation (62)
Indications (28)
Infectious disease (1790)
Inflammatory bowel disease (109)
Inflation Reduction Act (6)
Influenza (37)
Intellectual property (81)
Interviews (51)
IPO (9403)
IRA (30)
Job creations (1575)
Job search strategy (350)
Kidney cancer (8)
Labor market (12)
Layoffs (200)
Leadership (9)
Legal (3363)
Liver cancer (49)
Lung cancer (242)
Lymphoma (121)
Machine learning (7)
Management (23)
Manufacturing (254)
MASH (49)
Medical device (10209)
Medtech (10211)
Mergers & acquisitions (11678)
Metabolic disorders (514)
Multiple sclerosis (56)
NASH (13)
Neurodegenerative disease (60)
Neuropsychiatric disorders (15)
Neuroscience (1361)
NextGen: Class of 2025 (4213)
Non-profit (3221)
Now hiring (11)
Obesity (268)
Opinion (128)
Ovarian cancer (60)
Pain (72)
Pancreatic cancer (55)
Parkinson's disease (107)
Partnered (19)
Patents (186)
Patient recruitment (94)
Peanut (36)
People (39110)
Pharmaceutical (52)
Pharmacy benefit managers (9)
Phase I (12067)
Phase II (17244)
Phase III (14893)
Pipeline (904)
Policy (96)
Postmarket research (1718)
Preclinical (4663)
Press Release (53)
Prostate cancer (84)
Psychedelics (12)
Radiopharmaceuticals (232)
Rare diseases (288)
Real estate (3540)
Recruiting (29)
Regulatory (15050)
Reports (23)
Research institute (1895)
Resumes & cover letters (44)
Rett syndrome (5)
RNA editing (3)
RSV (24)
Schizophrenia (50)
Series A (112)
Series B (79)
Service/supplier (9)
Sickle cell disease (43)
Special edition (7)
Spinal muscular atrophy (98)
Sponsored (17)
Startups (2471)
State (1)
Stomach cancer (8)
Supply chain (54)
Tariffs (34)
The Weekly (17)
Vaccines (433)
Venture capitalists (29)
Weight loss (159)
Women's health (28)
Worklife (8)
Date
Today (112)
Last 7 days (696)
Last 30 days (2045)
Last 365 days (25321)
2025 (8439)
2024 (26879)
2023 (29431)
2022 (37979)
2021 (40548)
2020 (37957)
2019 (33606)
2018 (25362)
2017 (22479)
2016 (21176)
2015 (23587)
2014 (16946)
2013 (13756)
2012 (14626)
2011 (14438)
2010 (12557)
Location
Africa (423)
Alabama (41)
Alaska (4)
Arizona (102)
Arkansas (13)
Asia (26475)
Australia (3888)
California (4288)
Canada (1665)
China (475)
Colorado (194)
Connecticut (215)
Delaware (132)
Europe (61888)
Florida (713)
Georgia (152)
Idaho (34)
Illinois (443)
India (24)
Indiana (277)
Iowa (9)
Japan (150)
Kansas (61)
Kentucky (11)
Louisiana (8)
Maine (29)
Maryland (605)
Massachusetts (3547)
Michigan (140)
Minnesota (270)
Mississippi (2)
Missouri (79)
Montana (25)
Nebraska (14)
Nevada (48)
New Hampshire (52)
New Jersey (1440)
New Mexico (23)
New York (1347)
North Carolina (777)
North Dakota (8)
Northern California (1846)
Ohio (155)
Oklahoma (13)
Oregon (30)
Pennsylvania (1035)
Puerto Rico (6)
Rhode Island (28)
South America (579)
South Carolina (21)
South Dakota (1)
Southern California (1603)
Tennessee (87)
Texas (623)
United States (17314)
Utah (142)
Virginia (117)
Washington D.C. (51)
Washington State (423)
West Virginia (1)
Wisconsin (61)
430,600 Results for "innovative medicines canada".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Low-Price Drug Nations Catching ‘Free Ride’ on US Innovation, Report Says
No Patient Left Behind says that drug value assessments used in countries like Canada and Germany undervalue innovative medicines by 90% and mislead U.S. policymakers into thinking Americans are overpaying.
May 2, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis
April 14, 2025
·
4 min read
Drug Development
Innovative Medicines Canada Urges Provinces to Accelerate Access to Medicines
July 17, 2024
·
2 min read
Cell therapy
Galapagos to Spin Out Innovative Medicines, Lay Off 40%
By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell therapy company, the latter of which will inherit the Galapagos name.
January 8, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
April 9, 2025
·
5 min read
Press Releases
Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura in Canada
April 16, 2025
·
8 min read
Press Releases
SKYCLARYS™ (omaveloxolone) Approval by Health Canada Ushers in a New Era for Friedreich’s Ataxia Treatment in Canada
March 17, 2025
·
7 min read
Press Releases
Pfizer’s IXIFI® will be available in Canada as of April 1, 2025
March 18, 2025
·
3 min read
Press Releases
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central America
January 15, 2025
·
6 min read
Press Releases
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America
January 14, 2025
·
6 min read
1 of 43,060
Next
